Latest Breaking News On - Fennec pharmaceuticals inc - Page 6 : comparemela.com

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CFO Sells $153,725 00 in Stock

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CFO Sells $153,725 00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesCraig hallumGendell jeffreyRobert andradeQuarter for fennec pharmaceuticalsVanguard group incBlackrock incNews ratings for fennec pharmaceuticals dailyFennec pharmaceuticalsFennec pharmaceuticals incFennec pharmaceuticals tradingCapital managementSecurities exchange commissionGet free reportExchange commissionPharmaceuticals inc

Analysts Set Expectations for Fennec Pharmaceuticals Inc s FY2028 Earnings (TSE:FRX)

Analysts Set Expectations for Fennec Pharmaceuticals Inc s FY2028 Earnings (TSE:FRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Fennec pharmaceuticals price performanceFennec pharmaceuticals incFennec pharmaceuticalsNews ratings for fennec pharmaceuticals dailyFree reportCapital one financialOne financialFennec pharmaceuticalGet free reportPharmaceuticals incFennec pharmaceuticals daily

Equities Analysts Offer Predictions for Fennec Pharmaceuticals Inc s FY2028 Earnings (TSE:FRX)

Equities Analysts Offer Predictions for Fennec Pharmaceuticals Inc s FY2028 Earnings (TSE:FRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Fennec pharmaceuticals stock performanceFennec pharmaceuticals incFennec pharmaceuticalsNews ratings for fennec pharmaceuticals dailyFree reportCapital one financialOne financialFennec pharmaceuticalGet free reportPharmaceuticals incFennec pharmaceuticals daily

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CFO Sells 13,975 Shares of Stock

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CFO Sells 13,975 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesRobert andradeCraig hallumFennec pharmaceuticals stock performanceQuarter for fennec pharmaceuticalsFennec pharmaceuticalsInstitutional trading of fennec pharmaceuticalsSecurities exchange commissionRoyal bankTower research capitalNews ratings for fennec pharmaceuticals dailyFennec pharmaceuticals incGet free reportExchange commissionPharmaceuticals incResearch capital

Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

~ Fourth Quarter 2023 Net Revenues of Approximately $9.2 to $9.7 Million ~ ~ Company Expects to Report 2023 Fourth Quarter and Audited Full-Year Results on or about March 26, 2024 ~ RESEARCH.

United statesRobert andradeLindsay roccoExchange commissionFennec pharmaceuticals incElixir health public relationsCompany expects toClinical oncology groupDrug administrationOregon healthFennec pharmaceuticalsEuropean commission marketing authorizationScience universityFourth quarterCompany expectsAudited full year results